Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postpartum thyroid diseases through the ages: a historical view

R C Smallridge1

  • 1Division of Endocrinology, Mayo Clinic Jacksonville, Florida 32224, USA. Smallridge.robert@mayo.edu

Thyroid : Official Journal of the American Thyroid Association
|August 14, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial.

The Journal of clinical endocrinology and metabolism·2013
Same author

Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.

The Journal of clinical endocrinology and metabolism·2012
Same author

Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.

Clinical oncology (Royal College of Radiologists (Great Britain))·2010
Same author

Hormonal and cardiovascular response to low-intensity exercise with atropine administration.

Military medicine·2009
Same author

Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.

The Journal of clinical endocrinology and metabolism·2007
Same author

Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1.

Oncogene·2005